NICE "yes" for Allergan's Ozurdex after comparison with off-label Avastin
07 June 2011
Francesca Bruce
Please Login to read the full article.
07 June 2011
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE no for Novartis' Lucentis is good news for Allergan's Ozurdex
- SMC vetoes Sanofi's Jevtana, AZ's Vimovo and Merck's Emend, but OKs Simponi again
- Scotland says yes to Eliquis and Incivo but declines Ozurdex and Xgeva
- Allergan's Ozurdex to go eye-to-eye with Lucentis for BRVO
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
